Zoetis Inc Stock Today

ZTS Stock  USD 170.69  1.88  1.09%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 6

 
100  
 
Zero
Low
Zoetis is selling for under 170.69 as of the 18th of March 2024; that is -1.09% down since the beginning of the trading day. The stock's lowest day price was 170.41. Zoetis has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Zoetis Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of September 2022 and ending today, the 18th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
1st of February 2013
Category
Healthcare
Classification
Health Care
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis Inc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. The company has 457.87 M outstanding shares of which 3.77 M shares are at this time shorted by investors with about 1.64 days to cover. More on Zoetis Inc

Moving together with Zoetis Stock

  0.64DNA Ginkgo Bioworks Holdings Financial Report 8th of May 2024 PairCorr

Moving against Zoetis Stock

  0.61REVBW Revelation BiosciencesPairCorr
  0.58ERNA Eterna TherapeuticsPairCorr
  0.57LPCN Lipocine TrendingPairCorr
  0.53A Agilent Technologies Financial Report 28th of May 2024 PairCorr
  0.43JANX Janux Therapeutics Financial Report 14th of May 2024 PairCorr
  0.41REGN Regeneron Pharmaceuticals Financial Report 2nd of May 2024 PairCorr
  0.41ALVO Alvotech Earnings Call This WeekPairCorr

Zoetis Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Zoetis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zoetis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Zoetis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zoetis' managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEOKristin Peck
Thematic Ideas
(View all Themes)
Old NameZetes Industries SA
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, ARCA Pharmaceutical, SRI Sustainable Growth, Obamacare Repeal, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Analysts covering Zoetis report their recommendations after researching Zoetis' financial statements, talking to executives and customers, or listening in on Zoetis' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Zoetis Inc. The Zoetis consensus assessment is calculated by taking the average forecast from all of the analysts covering Zoetis.
Financial Strength
Based on the key indicators related to Zoetis' liquidity, profitability, solvency, and operating efficiency, Zoetis Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Zoetis Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.170.1641
Sufficiently Up
Slightly volatile
Asset Turnover0.680.5981
Fairly Up
Slightly volatile
Gross Profit Margin0.520.6828
Way Down
Pretty Stable
Net Debt3.4 B4.8 B
Way Down
Slightly volatile
Total Current Liabilities1.7 B1.9 B
Fairly Down
Slightly volatile
Non Current Liabilities Total5.6 B7.4 B
Way Down
Slightly volatile
Total Assets10.5 B14.3 B
Way Down
Slightly volatile
Total Current Assets4.9 B6.3 B
Way Down
Slightly volatile
Total Cash From Operating Activities1.3 B2.4 B
Way Down
Slightly volatile
Zoetis' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Zoetis' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Zoetis' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Zoetis' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zoetis' financial leverage. It provides some insight into what part of Zoetis' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Zoetis' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Zoetis deploys its capital and how much of that capital is borrowed.
Liquidity
Zoetis cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 6.8 B in debt with debt to equity (D/E) ratio of 1.48, which is OK given its current industry classification. Zoetis Inc has a current ratio of 2.14, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Zoetis until it has trouble settling it off, either with new capital or with free cash flow. So, Zoetis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Zoetis Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Zoetis to invest in growth at high rates of return. When we think about Zoetis' use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

29.45 Million
Zoetis Inc (ZTS) is traded on New York Stock Exchange in USA. It is located in 10 Sylvan Way, Parsippany, NJ, United States, 07054 and employs 14,100 people. Zoetis is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 79.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zoetis's market, we take the total number of its shares issued and multiply it by Zoetis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zoetis Inc runs under Pharmaceuticals sector within Health Care industry. The entity has 457.87 M outstanding shares of which 3.77 M shares are at this time shorted by investors with about 1.64 days to cover. Zoetis Inc has about 3.58 B in cash with 2.35 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.88.
Check Zoetis Probability Of Bankruptcy
Ownership Allocation
Zoetis Inc owns a total of 457.87 Million outstanding shares. The majority of Zoetis outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zoetis Inc to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zoetis Inc. Please pay attention to any change in the institutional holdings of Zoetis Inc as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Zoetis Ownership Details

Zoetis Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Zoetis jumping above the current price in 90 days from now is close to 99%. The Zoetis Inc probability density function shows the probability of Zoetis stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.5643. This usually means as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Zoetis will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Zoetis Inc is significantly underperforming NYSE Composite.
  Odds Below 170.69HorizonTargetOdds Above 170.69
0.12%90 days
 170.69 
99.88%
Based on a normal probability distribution, the odds of Zoetis to move above the current price in 90 days from now is close to 99 (This Zoetis Inc probability density function shows the probability of Zoetis Stock to fall within a particular range of prices over 90 days) .

Zoetis Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Zoetis that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zoetis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zoetis' value.
InstituionRecorded OnShares
Wellington Management Company Llp2023-12-31
M
Goldman Sachs Group Inc2023-12-31
M
Fmr Inc2023-12-31
7.9 M
Nuveen Asset Management, Llc2023-12-31
6.5 M
Northern Trust Corp2023-12-31
5.9 M
Polen Capital2023-12-31
M
Norges Bank2023-12-31
M
Bank Of New York Mellon Corp2023-12-31
4.4 M
Legal & General Group Plc2023-12-31
4.2 M
Vanguard Group Inc2023-12-31
40.3 M
Blackrock Inc2023-12-31
36.5 M
View Zoetis Diagnostics

Zoetis Historical Income Statement

Zoetis Inc Income Statement is one of the three primary financial statements used for reporting Zoetis's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zoetis Inc revenue and expense. Zoetis Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Zoetis' Depreciation And Amortization is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 3.1 B in 2024, whereas Total Revenue is likely to drop slightly above 6 B in 2024. View More Fundamentals

Zoetis Stock Against Markets

Picking the right benchmark for Zoetis stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Zoetis stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Zoetis is critical whether you are bullish or bearish towards Zoetis Inc at a given time. Please also check how Zoetis' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Zoetis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Zoetis Corporate Directors

Zoetis corporate directors refer to members of a Zoetis board of directors. The board of directors generally takes responsibility for the Zoetis' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Zoetis' board members must vote for the resolution. The Zoetis board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
William SteereIndependent DirectorProfile
Linda RhodesIndependent DirectorProfile
Frank DAmelioIndependent DirectorProfile
Robert ScullyIndependent DirectorProfile

How to buy Zoetis Stock?

Before investing in Zoetis, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Zoetis. To buy Zoetis stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Zoetis. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Zoetis stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Zoetis Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Zoetis Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Zoetis Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Zoetis Stock please use our How to Invest in Zoetis guide.

Already Invested in Zoetis Inc?

The danger of trading Zoetis Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zoetis is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zoetis. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zoetis Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Zoetis Stock analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Zoetis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zoetis. If investors know Zoetis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zoetis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.164
Dividend Share
1.5
Earnings Share
5.07
Revenue Per Share
18.527
Quarterly Revenue Growth
0.085
The market value of Zoetis Inc is measured differently than its book value, which is the value of Zoetis that is recorded on the company's balance sheet. Investors also form their own opinion of Zoetis' value that differs from its market value or its book value, called intrinsic value, which is Zoetis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zoetis' market value can be influenced by many factors that don't directly affect Zoetis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zoetis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.